Duloxetine and pregabalin in neuropathic pain of lung cancer patients.

ABSTRACT:

Introduction

Neuropathic pain occurs in 1% of the population and is difficult to manage. This chronic pain causes psychological distress and impacts patient's quality of life, especially in cancer patients. The aim of this study was to show and compare the efficacy of pregabalin and duloxetine, which are reported in the group of first-line treatment at European Federation of Neurological Societies (EFNS) guidelines on the pharmacological treatment of neuropathic pain (2010 revision) in lung cancer patients by using visual analogue scale (VAS) and Leeds Assessment of Neuropathic Symptoms and Sign (LANSS).

Patients and methods

A prospective, randomized, open label, 3 month of study was conducted. A total of 44 patients that were diagnosed with neuropathic pain (14 women and 30

SUBMITTER: Gul SK 

PROVIDER: S-EPMC7066365 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature